Purchase of a microcomputer controlled steam steri   2

Background
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has issued a Sources Sought notice to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement. The notice provides background information on the RADx Initiative, created during the COVID-19 pandemic to speed the development, commercialization, and implementation of technologies for COVID-19 testing. The RADx Variant Task Force focuses on genotyping assays with a discreet set of markers that distinguish the variety of subvariants in circulation at a given time. The purpose is to track both the virus’ presence and to understand which variants are active and/or emerging in the community.

Work Details
The work involves support for variant tracking through entities that execute genotyping assays and report to the RADx supported dashboard. Providers are required to acquire positive SARS-CoV-2 samples representative of the community in a capacity that supports 1,000 or more samples per week, execute RADx designed genotyping assays with at least 4 markers and turnaround sample-to-answer in less than 2 days, update and validate new marker sets within two weeks, and perform genotyping assays on samples with viral loads of 10-1000 copies per reaction. Additionally, respondents are required to submit a capability statement addressing specific project requirements, including documented experience with sample processing of genotyping assays at rates greater than 1,000 samples per week, access to positive SARS-CoV-2 samples, geographical distribution from which samples can be acquired and reported within their network, description of facilities and equipment available, company information, GSA Schedule Contracts, company type as shown in SAM, and UEI (formally DUNS) number.

Place of Performance
United States